東方電氣(01072.HK)完成配售6800萬股 淨籌約10.7億港元
格隆匯9月24日丨東方電氣(01072.HK)宣佈,配售事項已於2025年9月24完成。合共6800萬股配售股份(相當於已發行H股總數的約16.67%,及經配發及發行配售股份擴大後之已發行股份總數的約1.97%)已按每股配售股份15.92港元的配售價成功配售予不少於六名承配人。
配售事項所得款項總額及所得款項淨額將分別約爲10.8億港元及10.7億港元。公司擬將配售事項所得款項淨額用作一般營運資金,其中(i)約50%配售事項所得款項淨額,或約5.37億港元,用於研發注資;及(ii)約50%配售事項所得款項淨額,或約5.37億港元,用於擴展公司銷售渠道。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.